BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22194013)

  • 1. Large chromatin domains in pluripotent and differentiated cells.
    Hu S; Cheng L; Wen B
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):48-53. PubMed ID: 22194013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of pluripotency.
    Chen L; Daley GQ
    Hum Mol Genet; 2008 Apr; 17(R1):R23-7. PubMed ID: 18632692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of telomere chromatin integrity in pluripotent embryonic stem cells.
    Wong LH
    Epigenomics; 2010 Oct; 2(5):639-55. PubMed ID: 22122049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin remodeling in embryonic stem cells: regulating the balance between pluripotency and differentiation.
    Keenen B; de la Serna IL
    J Cell Physiol; 2009 Apr; 219(1):1-7. PubMed ID: 19097034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide epigenetic analysis of human pluripotent stem cells by ChIP and ChIP-Seq.
    Hitchler MJ; Rice JC
    Methods Mol Biol; 2011; 767():253-67. PubMed ID: 21822881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional control of embryonic and induced pluripotent stem cells.
    Guenther MG
    Epigenomics; 2011 Jun; 3(3):323-43. PubMed ID: 22122341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.
    Atkinson S; Armstrong L
    Cell Tissue Res; 2008 Jan; 331(1):23-9. PubMed ID: 18004593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and large scale spatial organization of the genome.
    Joffe B; Leonhardt H; Solovei I
    Curr Opin Genet Dev; 2010 Oct; 20(5):562-9. PubMed ID: 20561778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cell differentiation: a chromatin perspective.
    Rasmussen TP
    Reprod Biol Endocrinol; 2003 Nov; 1():100. PubMed ID: 14614777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin in pluripotent embryonic stem cells and differentiation.
    Meshorer E; Misteli T
    Nat Rev Mol Cell Biol; 2006 Jul; 7(7):540-6. PubMed ID: 16723974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin plasticity and genome organization in pluripotent embryonic stem cells.
    Mattout A; Meshorer E
    Curr Opin Cell Biol; 2010 Jun; 22(3):334-41. PubMed ID: 20226651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation.
    Krejcí J; Uhlírová R; Galiová G; Kozubek S; Smigová J; Bártová E
    J Cell Physiol; 2009 Jun; 219(3):677-87. PubMed ID: 19202556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulatory mechanisms during preimplantation development.
    Corry GN; Tanasijevic B; Barry ER; Krueger W; Rasmussen TP
    Birth Defects Res C Embryo Today; 2009 Dec; 87(4):297-313. PubMed ID: 19960551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and artificial routes to pluripotency.
    Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
    Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.
    Sumer H; Liu J; Verma PJ
    Theriogenology; 2010 Sep; 74(4):525-33. PubMed ID: 20615537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic regulators of pluripotency.
    Surani MA; Hayashi K; Hajkova P
    Cell; 2007 Feb; 128(4):747-62. PubMed ID: 17320511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.